[
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Upgrades HCA Healthcare, Inc.’s (HCA) Price Target, Citing Strategic Strengths",
    "summary": "Cantor Fitzgerald elevated HCA Healthcare, Inc.’s (NYSE:HCA) price target to $444 from $405 on May 21, 2025, reaffirming an Overweight rating. The adjustment arises from to analyst’s confidence in the healthcare giant’s operational resilience and growth trajectory and reflects a 16% potential upside from the stock’s current closing price of $381.81. HCA Healthcare, Inc. (NYSE:HCA), […]",
    "url": "https://finnhub.io/api/news?id=792acb9d0a8a03fc818d35976533117822bb90f2428d1f4af7452a50ee025c48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747972692,
      "headline": "Cantor Fitzgerald Upgrades HCA Healthcare, Inc.’s (HCA) Price Target, Citing Strategic Strengths",
      "id": 134658874,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Cantor Fitzgerald elevated HCA Healthcare, Inc.’s (NYSE:HCA) price target to $444 from $405 on May 21, 2025, reaffirming an Overweight rating. The adjustment arises from to analyst’s confidence in the healthcare giant’s operational resilience and growth trajectory and reflects a 16% potential upside from the stock’s current closing price of $381.81. HCA Healthcare, Inc. (NYSE:HCA), […]",
      "url": "https://finnhub.io/api/news?id=792acb9d0a8a03fc818d35976533117822bb90f2428d1f4af7452a50ee025c48"
    }
  }
]